HemostOD Secures CHF 2 Million in Innosuisse Funding to Advance Donor-Free Platelet Preclinical Development
Wedoany.com Report on Feb 10th, HemostOD announced that it has secured CHF 2 million (approximately USD 2.5 mil...
Bystronic Switzerland Successfully Completes Acquisition of Coherent Inc.'s "Tools for Materials Processing Business Unit and Rofin Brand," Officially Establishes Bystronic rofin Business Unit
Bystronic Switzerland successfully completed the acquisition of Coherent Inc.'s "Tools for Materials...
Lattice Surgery Achieves Breakthrough in Fault-Tolerant Operation of Superconducting Qubits
The Quantum Device Lab at ETH Zurich has achieved a significant breakthrough in the field of superco...
GBAC Releases Quantum Strategic Intelligence Standards to Build Governance Framework for the Quantum AI Era
The Global Blockchain Applications Council recently released the Quantum Strategic Intelligence Stan...
Integration of Structured Reporting with AI Significantly Reduces Radiology Report Turnaround Time
The integration of artificial intelligence with structured reporting has brought significant efficie...
Philippines Partners with Swiss Company to Establish Digital Carbon Office for Agricultural Carbon Credit Trading
Wedoany.com Report on Feb 5th,During the annual meeting of the World Economic Forum in Davo...
Swiss Study Reveals Early PV Module Degradation Rates Lower Than Expected, Material Design is Key Factor
A research team from the University of Applied Sciences and Arts of Southern Switzerland (SUPSI) rec...
Azerbaijan's IDEA Union and IUCN Discuss Environmental Cooperation and Sign Statement of Intent in Switzerland
Leyla Aliyeva, Vice President of the Heydar Aliyev Foundation of Azerbaijan and Head of the IDEA Pub...
Financing + Offtake: Abcourt Secures $30 Million Strategic Partnership with Glencore
Canadian mining company Abcourt Mines recently announced a significant cooperation agreement with th...
Roche CEO Points to Higher Future Drug Prices in Switzerland After US Deal
Wedoany.com Report-Dec.22, Agreements between pharmaceutical companies and the United States to lowe...